Seagen (SGEN) Peer Comparison

$228.74

$0.00 (0.00%)

As on 22-Dec-2023 09:30EDT

Market cap

$43,155 Mln

Revenue (TTM)

$2,300 Mln

P/E Ratio

P/B Ratio

16.9

Div. Yield

0 %

Edit

	Seagen (SGEN)	Miromatrix Medical Inc (MIRO)	Acer Therapeutics Inc. (DE) (ACER)	Neoleukin Therapeutics (NLTX)
Market cap ($ Mln)	43,155	93	16	8
Revenue ($ Mln)	2,300	1	0	--
Net Profit ($ Mln)	-750.23	-27.12	-60.92	-39.36
Net Margin (%)	-32.61	-2,430.11	1,778.97	281,135.71
RoE (%)	-28.45	-125.15	--	-54.63
Price to Earnings	--	--	--	--
Price-To-Book	16.92	5.98	17.26	0.44

Income Statement ($ Mln)

	Seagen (SGEN)	Miromatrix Medical Inc (MIRO)	Acer Therapeutics Inc. (DE) (ACER)	Neoleukin Therapeutics (NLTX)
Operating Revenue	1,962.41	0.95	0.00	0.00
Cost of Revenue	410.06	0.50	--	--
Gross Profit	1,552.35	0.45	1.26	0.01
Operating Expenses	2,165.32	30.70	24.61	59.10
Operating Profit (EBIT)	-612.97	-30.25	-24.61	-59.10
Other Income	--	--	--	0.01
Profit before Tax	-602.32	-29.96	-26.24	-57.56
Provision for Tax	7.99	0.05	1.62	-1.54
Profit after Tax (Net Income)	-610.31	-30.01	-27.86	-56.02
Minority Interest	--	--	--	--
Consolidated Profit	-610.31	-14.67	-15.37	-57.56

	Seagen (SGEN)	Miromatrix Medical Inc (MIRO)	Acer Therapeutics Inc. (DE) (ACER)	Neoleukin Therapeutics (NLTX)
Shareholder's Funds	2,803.82	26.11	-16.76	94.33
Minority Interest	--	--	--	--
Non-Current Liabilities	52.31	3.71	9.43	10.56
Current Liabilities	818.40	4.95	18.95	11.06
Total Liabilities	3,674.53	34.76	11.62	115.95

	Seagen (SGEN)	Miromatrix Medical Inc (MIRO)	Acer Therapeutics Inc. (DE) (ACER)	Neoleukin Therapeutics (NLTX)
Non-Current Assets	1,939.46	7.45	8.11	16.81
Current Assets	1,735.07	27.31	3.52	99.13
Total Assets	3,674.53	34.76	11.62	115.95
Total Debt*	43.47	3.55	11.86	12.07
Net Current Assets	1,984.13	22.36	-15.44	88.07

	Seagen (SGEN)	Miromatrix Medical Inc (MIRO)	Acer Therapeutics Inc. (DE) (ACER)	Neoleukin Therapeutics (NLTX)
Cash From Operating Activities	-453.75	-26.68	-30.25	-45.61
Cash Flow from Investing Activities	228.24	-1.38	-0.05	-59.13
Cash from Financing Activities	125.36	0.17	20.04	0.16
Net Cash Inflow / Outflow	-100.15	--	--	-50.09

	Seagen (SGEN)	Miromatrix Medical Inc (MIRO)	Acer Therapeutics Inc. (DE) (ACER)	Neoleukin Therapeutics (NLTX)
ROCE (%)	-20.45	-70.93	894.87	-42.72
ROE (%)	-20.80	-74.80	301.44	-47.23
ROA (%)	-16.51	-62.72	-116.37	-40.13
EBIT Margin (%)	--	--	--	--
Net Margin (%)	-31.10	-3,147.22	-1,168.94	-486,791.67
Cash Profit Margin (%)	--	--	--	--

	Seagen (SGEN)	Miromatrix Medical Inc (MIRO)	Acer Therapeutics Inc. (DE) (ACER)	Neoleukin Therapeutics (NLTX)
Revenue Growth (%)	0.25	27.84	-1.00	-1.00
EBIT Growth (%)	--	--	--	--
Net Profit Growth (%)	9.51	-100.64	-89.16	4.11
EPS Growth (%)	0.11	-0.05	-0.66	0.04
Book Value Growth (%)	--	--	--	--

	Seagen (SGEN)	Miromatrix Medical Inc (MIRO)	Acer Therapeutics Inc. (DE) (ACER)	Neoleukin Therapeutics (NLTX)
Price / Earnings	-39.18	-2.09	-1.44	-0.50
Price / Book Value	8.53	2.41	-2.40	0.30
Dividend Yield (%)	--	--	--	--
EV/EBITDA	-35.64	-1.38	-2.00	0.99
Market Cap ($ Cr)	--	--	--	--

	Seagen (SGEN)	Miromatrix Medical Inc (MIRO)	Acer Therapeutics Inc. (DE) (ACER)	Neoleukin Therapeutics (NLTX)
Debt to Equity	0.02	0.14	-0.71	0.13
Short term debt to equity ratio	--	0.02	-0.15	0.02
Current Ratio	2.12	5.52	0.19	8.96
Quick Ratio	1.60	5.36	0.93	--
Interest Coverage	-5.92	-633.66	-242.67	-37.36

	Seagen (SGEN)	Miromatrix Medical Inc (MIRO)	Acer Therapeutics Inc. (DE) (ACER)	Neoleukin Therapeutics (NLTX)
Debtors to sales (%)	25.58	108.89	396.83	--
Asset Turnover	0.53	0.02	0.00	0.00
Receivable days	82.93	443.02	1,449.40	54,787.50
Inventory Days	279.63	584.47	--	--
Payable days	143.71	1,344.04	--	--
Cash Conversion Cycle	218.86	-316.54	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.